$5.23
-0.02-0.38%
At close: Aug 25, 5:00 PM EST
$5.24
-0.01-0.19%
Pre-Market: 4:15 AM EST
Wave Life Sciences (WVE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.30 | $-0.32 | $-0.27 | $-0.30 |
| Actual | $-0.34 | $-0.13 | $-0.30 | $-0.32 |
| Surprise | -13.3% | +59.4% | -11.1% | -6.67% |
| Revenue | ||||
| Estimate | $7.4M | $8.5M | $14.2M | $11.5M |
| Actual | $2.3M | $38.2M | $17.2M | $7.6M |
| Surprise | -69.3% | +350.7% | +21.6% | -33.8% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.32 | $-0.34 | $-0.13 | $-0.34 |
| Revenue | ||||
| Consensus | $4.6M | $5.5M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $-0.34 | $-0.30 | -13.3 % |
| Q1 | Apr 28, 2026 | $-0.13 | $-0.32 | 59.4 % |
| Q4 | Feb 26, 2026 | $-0.30 | $-0.27 | -11.1 % |
| Q3 | Nov 10, 2025 | $-0.32 | $-0.30 | -6.67 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $2.27M | $7.40M | -69.3 % |
| Q1 | Apr 28, 2026 | $38.25M | $8.49M | 350.7 % |
| Q4 | Feb 26, 2026 | $17.24M | $14.18M | 21.6 % |
| Q3 | Nov 10, 2025 | $7.61M | $11.50M | -33.8 % |